6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Nayax to Report 2026 Q1 Earnings on May 12, 2026
27m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Janux Therapeutics Inc (NASDAQ:JANX) — investor relations, events, news, and company updates on 6ix.

Latest News

Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development

Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment

Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011

Financials

Revenue

$10 M

Market Cap

$902.74 M

EPS

-1.83

Community Chat

Ask AI